SecBot SecBot
8-K ·Filed Apr 7, 2026

HOLX

HOLOGIC INC
NEUTRAL
Impact 9/10
Horizonmonths Processed7mo ago SEC0001193125-26-144632
Killer combo: M&A completed + management change
Actionable Insight • Neutral

Traders should note that Hologic is no longer publicly traded, eliminating liquidity for existing shareholders. The CVR provides potential upside based on future revenue performance, but investors should monitor Hologic's Breast Health segment revenue to assess the likelihood of milestone achievement. The leadership change to Joe Almeida, an experienced MedTech executive, may influence future strategic direction.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK AT ENTRY AT T+1
Entry
$76.01
T+0 close · Apr 7, 2026 · via day close
Latest settled
0.00%
T+1 · $76.01
Vs SPY
−2.54%
α at T+1
Next horizon
T+5
due 7mo ago
  1. T+0 · Apr 7 $76.01entry
  2. T+1 · 7mo ago 0.00%α −2.54% · $76.01
  3. T+5 · due 7mo ago Pending
  4. T+20 · due 7mo ago Pending
  5. T+60 · due 5mo ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Hologic completed its acquisition by Blackstone and TPG, becoming a private company. The deal closed at $76 per share in cash plus a contingent value right (CVR) worth up to $3 per share based on future revenue milestones. The company was delisted from Nasdaq, all directors and the CEO resigned, and Joe Almeida was appointed as the new CEO.

Key Financial Metrics

Deal Value
$17.3B
Deal Type
acquisition

Key Facts

  • Hologic was acquired by Blackstone and TPG for $76 per share in cash plus a CVR worth up to $3 per share, totaling up to $79 per share.
  • The acquisition closed on April 7, 2026, making Hologic a private company.
  • Hologic's stock was delisted from Nasdaq following the acquisition.
  • All directors and CEO Stephen MacMillan resigned, with Joe Almeida appointed as the new CEO.
  • The CVR payments are contingent on achieving specific revenue milestones for Hologic's Breast Health business in fiscal years 2026 and 2027.

Financial Impact

Total transaction value of up to $79 per share, with $76 in cash and up to $3 in contingent payments. The total cash consideration was approximately $17.3 billion.

market_capshare_priceliquiditydebt

Risk Factors

  • CVR payments are contingent on future revenue performance and may not be realized.
  • Loss of public market liquidity for former shareholders.
  • Integration risks under new private ownership and leadership.

Market Snapshot

Exchange
Nasdaq
Sector
X-Ray Apparatus & Tubes & Related Irradiation Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-144632
Document: d135035dex32.htm0001193125-26-144632
Document: d135035d8k.htm0001193125-26-144632
Document: d135035dex991.htm0001193125-26-144632
Document: d135035dex31.htm0001193125-26-144632
Document: 0001193125-26-144632-index-headers.html0001193125-26-144632
Document: 0001193125-26-144632-index.html0001193125-26-144632
Document: 0001193125-26-144632.txt0001193125-26-144632

Track record

5 reports on HOLX

Performance horizon
Filters
  1. Apr 17, 202630w ago 15-12G Neutral 7/10 No price data
  2. Apr 13, 202631w ago EFFECT Neutral 3/10 No price data
  3. Apr 7, 202631w ago 8-K Neutral 9/10 Viewing Entry $76.01 No price data
  4. Apr 6, 202632w ago 8-K Neutral 7/10 Entry $76.01 No price data
  5. Feb 28, 202637w ago Institutional Cluster Mixed 6/10 Entry $75.45 to $75.55 ▲ +0.13% +8.07% vs SPY
Showing 5 of 5

US Market Status

Market Closed · Opens Wed (12h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 7, 2026